AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

China’s Cardiovascular Devices Market to 2024: Rapid Technological Advances to Boost Market Growth - ResearchAndMarkets.com

May 23, 2019

DUBLIN--(BUSINESS WIRE)--May 23, 2019--

The “China’s Cardiovascular Devices Market to 2024: Rapid Technological Advances to Boost Market Growth” report has been added to ResearchAndMarkets.com’s offering.

The China cardiovascular devices market was valued at USD 2837.61 million in 2018, and it is expected to reach USD 4468.02 million by 2024, with an anticipated CAGR of 7.86% during the forecast period, 2019-2024.

The increasing incidence of cardiovascular diseases and the growing geriatric population are the most significant factors driving the growth of the market.

According to a report by the United Nation Economic and Social Commission for Asia and the Pacific (ESCAP), the geriatric population in the Asia-Pacific region was around 617.1 million in 2015, accounting for more than half of the world’s total elderly population. By 2050, Asia-Pacific is estimated to account for almost two-thirds of the world’s geriatric population.

Furthermore, China’s population is aging at a faster rate than almost all other countries of the Asia-Pacific region, which is in part due to the long run of China’s one-child policy and the dramatic increase in healthcare facilities. According to the government estimates, the geriatric population may peak at more than 450 million geriatric citizens, by 2050.

The aging process is commonly associated with increased vascular rigidity and decreased vascular compliance. Elderly patients have a high risk of developing cardiovascular disorders, such as peripheral arterial disease (PAD), aortic disease, and venous thromboembolism (VTE). This is primarily due to age-related alterations in vascular structure and rigidity, further compounded by longer exposure to cardiovascular disease (CVD) risk factors.

Furthermore, other factors, such as the rapid technological advances, increasing awareness of the population, and high preference for minimally-invasive procedures, are also supplementing the market growth.

ECG Dominated the Diagnostic and Monitoring Segment

On the diagnostic and monitoring front, the new generation of portable and compact ECG are driving their greater adoption, especially in the home healthcare segment. The rising awareness and demand for minimally-invasive surgeries are driving the demand for coronary stents and valves. Furthermore, increasing incidence rates of cardiovascular diseases, such as arrhythmias, stroke, and high blood pressure, are driving the demand for cardiac rhythm management devices, including pacemakers and implantable defibrillators.

Competitive Landscape

Several local players, along with global medical device manufacturers. operate in the Chinese market. Local players dominate in the stent, catheter, and graft segments. However, the quality of products from global companies is perceived as superior. Thus, the premium segment of the cardiovascular devices market is dominated by global manufacturers.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rapid Technological Advances to Boost the Market Growth

4.2.2 Increasing Awareness among the Population

4.2.3 Increased Preference of Minimally-invasive Procedures

4.3 Market Restraints

4.3.1 Stringent Regulatory Policies

4.3.2 High Cost of Instruments and Procedures

4.4 Porter’s Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Device Type

5.1.1 Diagnostic and Monitoring Devices

5.1.1.1 Electrocardiogram (ECG)

5.1.1.2 Remote Cardiac Monitoring

5.1.1.3 Other Diagnostic and Monitoring Devices

5.1.2 Therapeutic and Surgical Devices

5.1.2.1 Cardiac Assist Devices

5.1.2.2 Cardiac Rhythm Management Device

5.1.2.3 Catheter

5.1.2.4 Grafts

5.1.2.5 Heart Valves

5.1.2.6 Stents

5.1.2.7 Other Therapeutic and Surgical Devices

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abbott Vascular

6.1.2 Boston Scientific Corporation

6.1.3 Mindray Medical International Limited

6.1.4 Edwards Life Sciences

6.1.5 W.L. Gore & Associates Inc.

6.1.6 Medtronic PLC

6.1.7 Biotronik Inc.

6.1.8 Lepu Medical Technology (Beijing) Co. Ltd.

6.1.9 Terumo Corporation

6.1.10 Microport Scientific Corporation

6.1.11 Getinge Group (Maquet Holding B.V. & Co. KG)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/ywpyka

View source version on businesswire.com:https://www.businesswire.com/news/home/20190523005369/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Cardiovascular Devices

KEYWORD: ASIA PACIFIC CHINA

INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/23/2019 08:00 AM/DISC: 05/23/2019 08:01 AM

http://www.businesswire.com/news/home/20190523005369/en

All contents © copyright 2019 The Associated Press.All rights reserved.